Does LISDEXAMFETAMINE DIMESYLATE Cause Psychomotor hyperactivity? 190 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 190 reports of Psychomotor hyperactivity have been filed in association with LISDEXAMFETAMINE DIMESYLATE (LISDEXAMFETAMINE DIMESYLATE). This represents 1.1% of all adverse event reports for LISDEXAMFETAMINE DIMESYLATE.
190
Reports of Psychomotor hyperactivity with LISDEXAMFETAMINE DIMESYLATE
1.1%
of all LISDEXAMFETAMINE DIMESYLATE reports
0
Deaths
13
Hospitalizations
How Dangerous Is Psychomotor hyperactivity From LISDEXAMFETAMINE DIMESYLATE?
Of the 190 reports, 13 (6.8%) required hospitalization, and 3 (1.6%) were considered life-threatening.
Is Psychomotor hyperactivity Listed in the Official Label?
Yes, Psychomotor hyperactivity is listed as a known adverse reaction in the official FDA drug label for LISDEXAMFETAMINE DIMESYLATE.
What Other Side Effects Does LISDEXAMFETAMINE DIMESYLATE Cause?
Drug ineffective (3,253)
Product availability issue (1,530)
Intentional overdose (1,131)
Product use issue (1,127)
Intentional self-injury (1,078)
No adverse event (1,025)
Anxiety (964)
Product quality issue (933)
Fatigue (923)
Inability to afford medication (913)
What Other Drugs Cause Psychomotor hyperactivity?
METHYLPHENIDATE (617)
QUETIAPINE (412)
ARIPIPRAZOLE (389)
OLANZAPINE (366)
SERTRALINE (288)
MONTELUKAST (282)
RISPERIDONE (277)
LEVETIRACETAM (247)
VENLAFAXINE (214)
LEVOTHYROXINE (211)
Which LISDEXAMFETAMINE DIMESYLATE Alternatives Have Lower Psychomotor hyperactivity Risk?
LISDEXAMFETAMINE DIMESYLATE vs LISINOPRIL
LISDEXAMFETAMINE DIMESYLATE vs LISOCABTAGENE MARALEUCEL
LISDEXAMFETAMINE DIMESYLATE vs LITHIUM
LISDEXAMFETAMINE DIMESYLATE vs LIXISENATIDE
LISDEXAMFETAMINE DIMESYLATE vs LOBAPLATIN